Currently there may be considerable delay before international normalised ratio (INR) results are available. Many patients wait for results to undergo cardiac catheterisation, cardio-version or discharge. Point of care (POC) INR technology may offer benefits to patients, health care staff and facilities. There are few studies reporting its efficacy and impact on cardiovascular disease inpatients on warfarin therapy, and none that report POC INR use in patients converting from heparin. The aim of this study was to compare the accuracy of INR results from POC testing with INR laboratory testing for patients receiving warfarin in an acute care setting and included patients being converted from intravenous heparin.
To read this article in full you will need to make a payment
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart, Lung and Circulation
Already a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
© 2007 Published by Elsevier Inc.